We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Spero Therapeutics
SPRO
$68.9M
| $157K | ﹤0.01% |
129,497
+51,434
| +66% | +$71.3K |
|
3477
BioLife Solutions
BLFS
$1.46B
| $154K | ﹤0.01% |
+11,126
| New | +$175K |
|
|
PMT
3478
PennyMac Mortgage Investment
PMT
$849M
| $153K | ﹤0.01% |
+12,362
| New | +$162K |
|
3479
Comscore
SCOR
| $153K | ﹤0.01% |
12,471
+7,045
| +130% | +$99.5K |
|
3480
Baytex Energy
BTE
$3.08B
| $152K | ﹤0.01% |
34,416
-250,568
| -88% | -$983K |
|
3481
Holley
HLLY
$314M
| $151K | ﹤0.01% |
+30,338
| New | +$172K |
|
3482
Clarus
CLAR
$125M
| $151K | ﹤0.01% |
19,985
-28,398
| -59% | -$227K |
|
3483
Perimeter Solutions
PRM
$5.5B
| $151K | ﹤0.01% |
+33,254
| New | +$185K |
|
|
AVDL
3484
DELISTED
Avadel Pharmaceuticals
AVDL
| $150K | ﹤0.01% |
+14,582
| New | +$195K |
|
3485
OFS Capital
OFS
$43.8M
| $150K | ﹤0.01% |
+13,334
| New | +$141K |
|
|
NGM
3486
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $149K | ﹤0.01% |
+139,659
| New | +$289K |
|
|
LGTY
3487
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $149K | ﹤0.01% |
13,029
-3,872
| -23% | -$42.9K |
|
3488
Puma Biotechnology
PBYI
$406M
| $149K | ﹤0.01% |
56,578
-34,409
| -38% | -$117K |
|
|
DEA
3489
Easterly Government Properties
DEA
$1.18B
| $148K | ﹤0.01% |
+5,186
| New | +$178K |
|
|
OMGA
3490
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $148K | ﹤0.01% |
+68,765
| New | +$275K |
|
3491
Prime Medicine
PRME
$533M
| $148K | ﹤0.01% |
+15,490
| New | +$201K |
|
3492
Scilex Holding
SCLX
$48.1M
| $147K | ﹤0.01% |
3,004
+2,301
| +327% | +$315K |
|
|
PFSW
3493
DELISTED
PFSweb, Inc.
PFSW
| $146K | ﹤0.01% |
19,627
-23,875
| -55% | -$125K |
|
|
ARI
3494
Apollo Commercial Real Estate
ARI
$887M
| $146K | ﹤0.01% |
+14,407
| New | +$157K |
|
|
CYT
3495
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $144K | ﹤0.01% |
+50,878
| New | +$140K |
|
3496
TFS Financial
TFSL
$5.1B
| $144K | ﹤0.01% |
12,220
-15,965
| -57% | -$214K |
|
|
VGR
3497
DELISTED
Vector Group Ltd.
VGR
| $144K | ﹤0.01% |
+13,498
| New | +$157K |
|
|
RENT
3498
Rent the Runway
RENT
$101M
| $143K | ﹤0.01% |
10,516
+3,910
| +59% | +$111K |
|
|
EMBJ
3499
Embraer S.A. ADS
EMBJ
$11.6B
| $143K | ﹤0.01% |
10,408
-2,195
| -17% | -$32.7K |
|
3500
Upland Software
UPLD
$12M
| $142K | ﹤0.01% |
3,065
-9,450
| -76% | -$345K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.